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Three-dimensional visualization of tissue structures using optical
microscopy facilitates the understanding of biological functions.
However, optical microscopy is limited in tissue penetration due to
severe light scattering. Recently, a series of tissue-clearing tech-
niques have emerged to allow significant depth-extension for
fluorescence imaging. Inspired by these advances, we develop a
volumetric chemical imaging technique that couples Raman-tailored
tissue-clearing with stimulated Raman scattering (SRS) microscopy.
Compared with the standard SRS, the clearing-enhanced SRS
achieves greater than 10-times depth increase. Based on the
extracted spatial distribution of proteins and lipids, our method
reveals intricate 3D organizations of tumor spheroids, mouse brain
tissues, and tumor xenografts. We further develop volumetric
phasor analysis of multispectral SRS images for chemically specific
clustering and segmentation in 3D. Moreover, going beyond the
conventional label-free paradigm, we demonstrate metabolic volu-
metric chemical imaging, which allows us to simultaneously map
out metabolic activities of protein and lipid synthesis in glioblas-
toma. Together, these results support volumetric chemical imaging
as a valuable tool for elucidating comprehensive 3D structures,
compositions, and functions in diverse biological contexts, comple-
menting the prevailing volumetric fluorescence microscopy.
volumetric imaging | stimulated Raman scattering | tissue clearing |
metabolic imaging | cancer metabolism
Three-dimensional structures of biological tissues are closelyassociated with their functions in both health and disease.
Representative examples range from neuroscience and cancer
biology, to developmental biology: 3D distributions of neurites
determine neuronal wiring of the brain (1–6); 3D interactions
between tumor cells and their microenvironment influence tu-
mor growth, invasion, and metastasis (7, 8); and 3D organ
morphogenesis reveals key mechanisms of embryonic develop-
ment (9, 10). Therefore, the ability to visualize structures and
functions of tissues in 3D is crucial for enhancing fundamental
understanding across biomedical disciplines.
Toward this goal, light microscopy presents an appealing tool to
noninvasively probe biological processes with subcellular resolution.
In particular, fluorescence microscopy is the method of choice for
bio-imaging, offering high sensitivity, molecular specificity, and
biocompatibility (11–13). However, its imaging depth is limited to
superficial layers of tissues due to inevitable light scattering origi-
nating from heterogeneous refractive indices (RIs) within tissues.
Typically, fluorescence imaging depth in tissues is limited to
∼500 μm (1 mm in rare cases), achieved by two-photon excited
fluorescence microscopy (14). A number of advanced techniques
have been developed to extend this depth limit, including adaptive
optics, longer excitation wavelengths, and higher-order nonlinear
excitation (15–19). Unfortunately, these techniques usually require
complicated instrumentations or procedures, and the achievable
depth extensions are often within a factor of two or three.
Recently, a series of tissue-clearing–based fluorescence micros-
copies have emerged and demonstrated remarkable results toward
volumetric visualization of whole organs (20, 21). Compared with
instrumentation-based approaches, these sample-centered methods
adopt a fundamentally different strategy by reducing light scattering
with active homogenization of tissue RIs (20, 21). Enabled by tissue
clearing, volumetric fluorescence imaging provides a window to
peer deep into a variety of tissues (e.g., brain, lung, bones) of dif-
ferent organisms in both physiology and pathology (e.g., Alz-
heimer’s disease, cancer) (7, 8, 22–25).
Complementary to fluorescence microscopy in many aspects,
stimulated Raman scattering (SRS) microscopy allows for imaging of
chemical bonds in biological samples with subcellular resolution. By
harnessing quantum amplification via stimulated emission, SRS mi-
croscopy offers bond-selective vibrational specificity with high sensi-
tivity (down to micromolars), fast acquisition (up to video-rate), and
general biocompatibility, making it a powerful technique for bio-
medicine (26–29). Compared with X-ray tomography (30), magnetic
resonance imaging (31), and positron emission tomography (32), SRS
offers higher spatial resolution and unique bond-selective specificity.
However, the typical imaging depth of SRS has been limited to
∼100 μm inside highly scattering tissues, such as the brain, because of
the scattering loss of laser power and overwhelming background (29).
In less scattering tissues, the imaging depth is still limited to 300–
500 μm. Therefore, extending SRS microscopy to deep volumetric
imaging (millimeter range) would provide holistic chemical in-
formation in a host of environments relevant to biomedicine.
Inspired by the success of tissue clearing, we devised an SRS-based
volumetric chemical imaging method to generate chemical-specific
3D maps deep into tissues. We note that many of tissue-clearing
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methods developed for volumetric fluorescence imaging alter the
tissue composition, and are thus unsuited for comprehensive
chemical imaging. Therefore, we identified two Raman-specific
criteria, developed a Raman-tailored tissue-clearing strategy, and
coupled it with SRS microscopy, including its advanced variations,
such as multispectral imaging and deuterium oxide (D2O) probing
coupled with SRS (DO-SRS) of metabolic probes (33) (Fig. 1A).
Our method achieves a greater than 10-times depth increase
compared with the standard SRS. We further developed a volu-
metric phasor analysis for 3D clustering and segmentation of
multispectral SRS images. With this whole toolkit, we reveal
complex 3D tissue structures, compositions, and functions in the
context of neurobiology and cancer biology.
Results
Development of Raman-Tailored Reagents for Clearing-Enhanced SRS
Imaging. To develop a clearing recipe tailored for SRS micros-
copy, we identified two Raman-specific criteria that differ from
those for volumetric fluorescence imaging. First, the tissue-clearing
chemicals should achieve certain “Raman transparency,” defined as
the ability to generate optically transparent tissues without in-
troducing interfering Raman signatures in the designated vibrational
windows. While a general method to create transparency across the
entire Raman spectrum, including the fingerprint region, would be
rather challenging, herein we focus on two important spectral win-
dows: the high-wavenumber C-H region (2,800–3,000 cm−1) and the
cell-silent region (1,800–2,600 cm−1). The vibrational signatures for
lipids and proteins are in the high-wavenumber C-H region, repre-
sented by CH2 (2,845 cm
−1) and CH3 (2,940 cm
−1) bands, re-
spectively (34, 35) (Fig. 1B). The interplay between proteins and
lipids has important implications in cancer (36, 37) and Alzheimer’s
disease (38, 39). For the cell-silent window, many emerging vibra-
tional tags reside in this region (40–44), allowing imaging of meta-
bolic dynamics of small metabolites and also super multiplexed
imaging (45, 46). Hence, our first criterion requires the clearing
reagents to make tissues optically transparent without introducing
Raman peaks in the CH region or the cell-silent region. Second, the
native chemical structures of examined tissues should be largely
preserved after tissue clearing. Here the clearing process should
maintain the integrity of both proteins and lipids. This is a rather
challenging requirement because many clearing methods [including
almost all organic-solvent and hydrogel-embedding–based methods
(20, 21)] are optimized for imaging specific proteins by removing
lipids to reduce the heterogeneity of RIs.
Based on the two Raman-specific criteria, we developed a clear-
ing recipe for Raman microscopy. We examined existing optical-
clearing reagents and identified urea as a promising candidate. In
fact, urea is the central component in Scale/ScaleS (2, 47). In terms
of our first criterion about Raman transparency, urea shows no
Raman peaks in a broad window from 1,800 to 3,000 cm−1 (SI
Appendix, Fig. S1A) by virtue of its unique structure containing only
N-H bonds, but no C-H bonds. In contrast, several common clearing
reagents—dibenzyl ether [3DISCO (22)], sorbitol [ScaleS (47)], and
fructose [SeeDB (5) and FRUIT (48)]—show strong Raman peaks
in the CH stretching region (2,800–3000 cm−1) (Fig. 1C), causing
severe background issues. To examine the second criterion about
maintenance of tissue integrity, we adopted the spontaneous Raman
Fig. 1. Development of clearing-enhanced SRS mi-
croscopy. (A) Set-up for clearing-enhanced SRS mi-
croscopy. (B) Spontaneous Raman spectra of 8 M
urea and 0.2% Triton X-100 (dark magenta), mouse
brain slices in PBS (light gray), slices cleared with 8 M
urea (dark gray), and slices cleared with 8 M urea
solution with 0.2% Triton X-100 (light magenta). (C)
Spontaneous Raman spectra of dibenzyl ether (red),
40% sorbitol solution (blue), 40% fructose solution
(yellow), and mouse brain slices in PBS (green, the
same as B). (D) Photos and the corresponding SRS
images (2,940 cm−1) close to depth limit (60, 500, and
800 μm) of 1-mm-thick brain slices in PBS, cleared
with 8 M urea, and with 8 M urea and 0.2% Triton X-
100, respectively. [Scale bars: 2 mm in the photos
(Upper), 50 μm in the SRS images (Lower).] (E)
Quantification of label-free imaging depths for dif-
ferent brain regions in PBS, cleared with 8 M urea,
and cleared with 8 M urea and 0.2% Triton X-100.
Error bars indicate SEM (n = 4, 6, and 4 for cortex,
white matter, and hippocampus in PBS. n = 4, 3, and
3 for cortex, white matter, and hippocampus in 8 M
urea. n = 3 for each brain region in 8 M urea and
0.2% Triton X-100). The imaging depth limit was
defined as the depth with signal-to-background ra-
tio of 0.5. (F) SRS images of regions in the same
white matter region before and after tissue clearing
(8 M urea with 0.2% Triton X-100). (Scale bars,
50 μm.) (G) Quantification of imaging depth with
clearing time (8 M urea with 0.2% Triton X-100).
Error bars indicate SD (n = 3 for each data point).
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spectrum as a benchmark because it is highly sensitive to chemical
structures. We observed minimum change of characteristic Raman
peaks in the CH stretching region for tissues incubated in 8 M urea
for 4 d (Fig. 1B, dark gray) compared with those in PBS (Fig. 1B,
light gray), indicating preservation of proteins and lipids. Our results
agree well with a previous report that urea can preserve the integrity
of both protein and lipid ultrastructures at the resolution of electron
microscopy (47).
After validating the two Raman-specific clearing criteria, we ver-
ified that a high concentration of urea (8 M) was capable of ren-
dering tissues substantially less opaque than the control (Fig. 1D).
This effect is likely due to the small size of urea that allows it to
penetrate, partially denature, and hydrate the hydrophobic core of
high-refractive index proteins (2, 20, 21, 47). We then performed
label-free SRS imaging on brain tissues cleared with urea. Indeed,
we did not observe background interference from high-concentration
urea in either band (2,845 cm−1 or 2940 cm−1). We defined the SRS
imaging depth limit as the depth at which the signal-to-background
ratio of SRS images at 2940 cm−1 reaches 0.5, below which imaging
contrast became too low. By this measure, we found that urea ex-
tended the SRS imaging depth for ∼5–10 times at different brain
regions (Fig. 1E). Representative SRS images (2,940 cm−1) of 1-mm-
thick brain slices are shown in Fig. 1D at depths close to the defined
imaging depth limits: 60 μm for the control slice in PBS and 500 μm
for the slice treated with 8M urea. This clearing solution of 8M urea
is well suited for volumetric chemical imaging of multicellular
spheroids (Fig. 2).
Improving Raman-Tailored Clearing for Volumetric SRS Imaging. To
improve Raman-tailored clearing for imaging deep tissues, we
asked whether adding auxiliary reagents could further improve
clearing performance. We found addition of 0.2% Triton X-100, a
typical detergent, allows substantial depth extension with well-
preserved features (axon fibers and cell bodies) in brain tissues (Fig.
1D). This is perhaps due to increased membrane permeability
effected by Triton X-100. Note that 0.2% Triton X-100 alone has
only marginal effect on imaging depth (SI Appendix, Fig. S2).
We next validated the fulfillment of two Raman-clearing criteria
with 8 M urea and 0.2% Triton X-100. First, 0.2% Triton X-
100 introduced no extra Raman background at the CH imaging-
window (Fig. 1B, dark magenta). Second, we found minimum
changes of characteristic Raman peaks in the CH region (Fig. 1B,
light magenta). We further confirmed the distributions of proteins
and lipids in tissues were preserved after clearing, using SRS imaging
at different brain regions. The SRS images of the same regions
aligned well with each other at the subcellular level before and after
clearing (Fig. 1F and SI Appendix, Fig. S3). We found a less than 7%
increase in protein/lipid ratio comparing the same regions before and
after clearing (SI Appendix). As a negative control, treating tissues
with a high concentration (15%) of Triton X-100 or the 3DISCO
method clearly disrupted the lipid structure (4, 22), as indicated by
the attenuation of the lipid peak at 2,845 cm−1 (SI Appendix, Figs.
S4A and S5A) and the disappearance of lipid-rich structures (nerve
tracts and axon fibers) (SI Appendix, Figs. S4B and S5B). While this
recipe of 8 M urea and 0.2% Triton X-100 preserved proteins and
lipids in tissues, it removed lipids from multicellular spheroids (SI
Appendix, Fig. S6), possibly because compact tissue structures are
more resistant to Triton X-100. Therefore, the basic recipe of 8 M
urea is the method of choice for volumetric chemical imaging of
spheroids (Fig. 2), while the improved recipe of 8 M urea and 0.2%
Triton X-100 was used for tissue samples.
Clearing-Enhanced SRS Imaging with Greater than 10 Times Depth
Extension. We then confirmed the optimal clearing time of the
improved recipe (8 M urea and 0.2% Triton X-100) on 1-mm-thick
coronal brain slices (Fig. 1G and SI Appendix, Fig. S7). The clearing
effect plateaued after a 4-d incubation (Fig. 1G). As reported
previously (2), we observed a slight volume expansion of cleared
brain tissues with an average expansion factor of 1.2 ± 0.1 (SI Ap-
pendix). Such a degree of expansion would allow moderately higher
imaging resolution, as is harnessed in expansion microscopy (49).
We next determined the depth extension of clearing-enhanced
SRS imaging. Remarkably, our improved Raman-tailored
clearing recipe increased the depth limit of SRS imaging by
17.2-fold (13.8-fold with correction for expansion) in the cerebral
cortex, 13.2-fold (10.6-fold with correction) in the white matter,
and 11.4-fold (9.1-fold with correction) in the hippocampus (Fig.
1E). The different depth extensions likely originated from varied
chemical compositions among these brain regions. For example,
the white matter has more lipids than the cortex and the hip-
pocampus, leading to higher RI heterogeneity, severer scatter-
ing, and thus a shallower imaging depth. In summary, we have
achieved label-free, dual-color volumetric chemical imaging ap-
proximately 1-mm deep in highly scattering tissues.
Clearing-Enhanced SRS Imaging of Whole Tumor Spheroids.With the
recipe of 8 M urea, we aimed to achieve volumetric imaging of
multicellular tumor spheroids. Tumor spheroids are widely used
in vitro models of solid tumors. Compared with 2D cultures,
tumor spheroids are considered to better mimic the 3D tumor
microenvironment and are thus increasingly used to study tumor
cell physiology and response of tumors to radiotherapy and
chemotherapy in a 3D multicellular context (50, 51). In addition
to the two-color label-free imaging, we further introduced a third
Fig. 2. Clearing-enhanced volumetric chemical imaging of 3D tumor
spheroids. (A–C) Three-dimensional reconstructions and representative 2D
images (at z = 22 μm, 120 μm, and 200 μm) of a tumor spheroid of MCF-
10AHras breast cells without tissue clearing. (D–F) Three-dimensional re-
constructions and representative 2D images (at z = 22 μm, 120 μm, and
200 μm) of a tumor spheroid of MCF-10AHras breast cells with tissue clear-
ing. Protein (magenta) and lipid (green) channels are overlaid in A and D.
Protein (magenta) and the d-PA (cyan) channels are overlaid in B and E. Lipid
(green) and d-PA (cyan) channels are overlaid in C and F. (Scale bars, 50 μm.)
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color for bioorthogonal chemical imaging (40, 41). This method
allowed imaging not only the spatial distributions of preexisting
proteins and lipids, but also the metabolic activity of newly
synthesized lipids by incubating spheroids with deuterated pal-
mitic acid (d-PA) (SI Appendix, Fig. S1B) (2,109 cm−1).
Without tissue clearing, SRS imaging of spheroids—prepared
from Ras-transformed MCF-10A breast epithelial cells—captured
the structure of no more than half of a spheroid (∼120 μm). The
spherical shape of multicellular aggregates with tight cellular
packing introduced severe light scattering (Fig. 2 A–C). In contrast,
with tissue clearing using 8 M urea, the distributions of proteins,
preexisting lipids, and newly synthesized lipids were visualized at
subcellular resolution throughout the entire spheroid (Fig. 2 D–F).
The intricate inner architecture of the spheroid was captured
showing the necrotic core (Fig. 2 D–F). Interestingly, while preex-
isting lipids were distributed relatively evenly throughout the whole
3D structure (Fig. 2 D–F, yellow), d-PA was preferentially in-
corporated into membrane structures of the cells at the invasion
front or the edge of the spheroid (Fig. 2 D–F, cyan). We speculate
that such differential enrichment might be correlated with higher
metabolic demand of the cells near the invasion front for cell di-
vision (52). Without tissue clearing, we could have mistakenly
concluded that these tumor spheroids had a hollow structure
without any preferential enrichment of newly synthesized lipids
(Fig. 2 A–C). Hence, we demonstrated that volumetric metabolic
imaging is informative for probing the heterogeneity of tumor ac-
tivity in 3D spherical models during invasion.
Clearing-Enhanced SRS Imaging of the Mouse Brain. The develop-
ment of volumetric imaging has been driven by a strong interest in
understanding 3D structure–function relationships in complex brain
networks. We thus conducted two-color clearing-enhanced SRS
imaging across a variety of mouse brain regions. Pure protein and
lipid images were obtained with a linear combination algorithm (SI
Appendix). As shown in Fig. 3A, this volumetric chemical imaging
method is capable of imaging from the hippocampus all the way to
the white matter with a total depth of ∼1.1 mm. In the hippocam-
pus, a key region involved in learning and memory, the distribution
of proteins highlights blood vessels and cell bodies while the dis-
tribution of lipids delineates axon fibers (Fig. 3A and SI Appendix,
Fig. S8 A, I, and M). Because of the effective clearing, the repre-
sentative 2D images at increasing depths maintained high-resolution
contrast for axon fibers, cell bodies, and even individual nucleoli
in the dentate gyrus (Fig. 3 B–E and SI Appendix, Fig. S8 B–D
and J–L). Compared with the hippocampus, the white matter con-
tains many lipid- and protein-rich nerve tracts (Fig. 3 A and F
and SI Appendix, Fig. S8 E–G, arrows) with complex topology,
likely related to its role in relaying information between dif-
ferent brain regions.
We also acquired volumetric images of other brain regions:
the cerebral cortex (Fig. 3G), the choroid plexus (Fig. 3H and SI
Appendix, Fig. S8H), and the olfactory bulb (Fig. 3I). In the ce-
rebral cortex, we observed partially aligned axon fibers (Fig. 3G,
arrowheads) together with several thick capillaries toward the
same direction (Fig. 3G, arrows). These results suggest an in-
terplay between axon guidance and angiogenesis (53), which
would be difficult to capture without volumetric imaging. Punc-
tate protein signals indicated cell bodies in the cortex (Fig. 3G,
stars). In addition, the choroid plexus was observed to be a
protein-rich plexus of cells surrounded by many lipid-rich nerve
tracts (Fig. 3H and SI Appendix, Fig. S8H), likely related to its
function of secreting cerebrospinal fluid into ventricles. In-
terestingly, we observed high-density axon fibers (Fig. 3I, arrows)
and cell bodies (Fig. 3I, arrowheads) in the olfactory bulb. These
results demonstrate two-color label-free volumetric chemical
imaging as a valuable method for providing 3D distributions of
blood vessels, axon fibers, and cell bodies in brain tissues with
chemical information.
Multispectral SRS Imaging with Volumetric Phasor Analysis. Next we
extended our technique to multispectral SRS imaging in which a
broad spectrum was acquired for every pixel, thus offering rich
spectroscopic information. To achieve robust 3D image segmenta-
tion for analysis and quantification, we developed a spectral phasor
method—sensitive to small spectral variations of multispectral
images—for volumetric chemical analysis in tissues. Different from the
phasor analysis performed on single-plane images (54), our volu-
metric phasor analysis transforms all voxels in the entire imaging
Fig. 3. Clearing-enhanced volumetric chemical im-
aging of various regions in mouse brain tissues. (A)
Three-dimensional reconstruction of the hippocam-
pus and white matter. Arrows indicate vasculatures,
arrowheads indicate axons, and stars indicate cell
bodies. (B–E) Representative 2D images at indicated
depths in A. (F) Three-dimensional reconstruction
and a representative 2D image of the white matter.
Arrows indicate nerve tracts. (G) Three-dimensional
reconstruction and a representative 2D image of the
cerebral cortex. Arrows indicate vasculatures, ar-
rowheads indicate axons, and stars indicate cell
bodies. (H) Three-dimensional reconstruction and a
representative 2D image of the choroid plexus. Ar-
rows indicate the choroid plexus and arrowheads
indicate nerve tracts. (I) Three-dimensional re-
construction and a representative 2D image of the
olfactory bulb. Arrows indicate axon fibers and ar-
rowheads indicate cell bodies. Proteins are in ma-
genta and lipids are in green. (Scale bars, 50 μm.)
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volume to phasor points on a single phasor plot (Fig. 4A).
Therefore, clustering and segmentation is performed collectively
for the entire imaging volume, resulting in systematic and holistic
segmentation of tissue components.
We demonstrated volumetric phasor analysis on mouse brain
tissues. To implement this analysis, we first acquired volumetric
multispectral images by taking z-stack images across 13 different
wavenumbers covering 2,810–3,090 cm−1 (SI Appendix). Second,
we generated a reference phasor plot by selectively cropping out
individual regions of axons, vasculature, nuclei, or extracellular
matrix and transforming these regions onto a phasor plot. In-
deed, each structure was identified as a separable cluster on the
reference phasor plot (SI Appendix, Fig. S9). Third, we trans-
formed the whole stack of volumetric multispectral images onto
a phasor plot (Fig. 4 B–D) and clustered this phasor plot
according to the reference phasor plot. Fourth, we projected
these clusters back to the volumetric image and evaluated the
clustering results. As shown in Fig. 4 B–D and SI Appendix, Fig.
S10, we reliably segmented axons, nuclei, vasculature, water, and
other components (including extracellular matrix and cellular
structures that were not resolved by SRS) in the cerebral cortex,
the hippocampus, and the white matter. The volume fractions of
tissue components showed that the hippocampus contained
more nuclei densely packed in the dentate gyrus than the cortex
and the white matter, while the white matter contained more
axons as nerve tracts than the other two brain regions (Fig. 4E).
These results indicate volumetric phasor analysis achieves rig-
orous, chemically specific segmentation for a large number of
species in 3D.
Clearing-Enhanced SRS Imaging of Tumors with Volumetric Phasor
Analysis. We applied the two-color label-free volumetric imag-
ing to capture 3D chemical information in tumor xenografts.
Glioblastoma multiforme is the most aggressive brain cancer with a
median survival time of ∼15 mo from diagnosis (55). To investigate
its 3D structure, we performed large-area mosaic imaging up to
700 μm into the glioblastoma xenograft in mouse brain (Fig. 5A).
The high-protein, low-lipid distribution of the tumor allowed de-
lineation of tumor margins (Fig. 5B) (36, 37). Single-plane images
at a series of depths through the same tumor (Fig. 5 A, C, and D
and SI Appendix, Fig. S11) revealed distinct features of normal
tissues, infiltrating glioma, and dense glioma (36, 37). Dense glioma
has a high level of proteins and a low level of lipids. In contrast,
normal brain tissues are lipid-rich, containing axon fibers and low
density of cell bodies. Infiltrating glioma at the tumor margins (Fig.
5 C and D, arrows, and SI Appendix, Fig. S11 B and C) show lipid-
rich areas of brain parenchyma with clusters of infiltrating glio-
blastoma cells. We validated this method of tumor demarcation by
immunolabeling with a human-specific vimentin antibody, which
specifically stained human-sourced tumor cells but not mouse cells
(SI Appendix, Fig. S12). The z-stack results indicate the margins of
the tumor differ at different imaging depths, as the size of the tu-
mor gradually expands with more complex structures from 200 to
700 μm (Fig. 5 A–D and SI Appendix, Fig. S11). We mapped out the
protein/lipid ratios (Sprotein/Slipid, the signal of the protein channel
over that of the lipid channel) of the whole coronal slices as a
function of depth (Fig. 5 E and F and SI Appendix, Fig. S13). This
single parameter indicates chemical heterogeneity, both between
tumor and normal tissues and within tumor tissues. These results
render volumetric chemical imaging a capable tool for capturing
Fig. 4. Volumetric phasor analysis. (A) Schematic
process of volumetric phasor analysis. Volumetric
phasor analysis provides segmentation of various
regions in mouse brains: the hippocampus (B), the
cerebral cortex (C), and the white matter (D). For B–
D, the phasor plot is shown (Left) and followed by
volumetric images of segmented species. “Other
components” include extracellular matrix and cellu-
lar structures that are not resolved by SRS. (E) Vol-
ume fraction of tissue components in the hippocampus
(B), the cerebral cortex (C), and the white matter (D).
(Scale bars, 50 μm.)
6612 | www.pnas.org/cgi/doi/10.1073/pnas.1813044116 Wei et al.
the complex geometry and composition of the tumor, because 2D
images at a single shallow depth could miss critical information.
Next we quantitatively analyzed tissue structures of brain glio-
blastoma using multispectral SRS imaging together with volumetric
phasor analysis. The reference phasor plot showed five clusters
representing axons, vasculature, tumor cells, extracellular matrix of
normal brain tissue, and normal cell nuclei (SI Appendix, Fig.
S14A). We segmented axons, vasculature, and tumor cells for fur-
ther analysis (Fig. 6A and SI Appendix, Fig. S14B). The distribution
of tumor cells showed the boundary between normal and dense
tumor tissues (Fig. 6A). With volumetric phasor analysis, infiltrating
tumor cells were readily identified to spread beyond tumor margins
and disperse in normal tissues (Fig. 6A, arrows). We validated
volumetric phasor analysis for identifying tumor margins and in-
filtrating tumor cells by immunolabeling (SI Appendix, Fig. S15) and
stimulated Raman histology (56) (SI Appendix, Fig. S16). In-
filtrating tumor cells are of clinical importance, because these cells
are often left behind after surgical resection and give rise to re-
currence and poor prognosis (36, 37). We hypothesized that these
properties of infiltrating tumor cells might be associated with their
unique chemical profile. To test this hypothesis, we selected indi-
vidual infiltrating tumor cells and dense tumor cells and trans-
formed the multispectral data of these cells onto a phasor plot (Fig.
6B). Indeed, these two types of tumor cells formed two clusters on
the phasor plot, indicating their differences in chemical composi-
tion (Fig. 6B). We then compared averaged single-cell SRS spec-
trum of infiltrating tumor cells to that of dense tumor cells (Fig.
6C). The spectrum of infiltrating tumor cells showed a slightly
higher shoulder peak, from 2,837 cm−1 to 2,921 cm−1, than that of
dense tumor cells (Fig. 6C). These spectral differences indicate a
higher lipid-to-protein ratio for the infiltrating tumor cells, which
was not known before and implies that glioblastoma exhibit cellular
heterogeneity in chemical composition. The altered composition of
infiltrating tumor cells might derive from their distinct metabolism
(57, 58) and enhance cell motility and invasion (59).
In addition, we found tumor tissues were associated with more
blood vessels and fewer axons than neighboring normal brain tis-
sues (Fig. 6A). Hence, we quantified the minimal distances from
individual tumor cells to vasculature and axons (Fig. 6D). Indeed,
the average minimal distance from tumor cells to axons was almost
three times of that to vasculature (Fig. 6D). We also found a much
higher volume fraction of vasculature but a much lower volume
fraction of axons in tumor tissues than those in normal tissues (Fig.
6 E and F). The differential distribution of axons agreed with
previous reports (36, 37). Furthermore, the vasculature in tumor
tissues contained very thick blood vessels and showed extravasation
of blood cells (Fig. 6A), which agreed with the abnormal structure
of dilated and leaky vasculature in the tumor (60). The high volume
fraction and abnormal morphology of tumor-associated vasculature
suggest the dysregulated, sustained process of angiogenesis, one of
the hallmarks of cancer (52). These heterogeneous information of
multiple species—revealing morphology and distributions inside
tissues in a label-free and quantitative manner—would be difficult
to acquire without volumetric phasor analysis on clearing-enhanced
multispectral SRS images.
Metabolic Volumetric Chemical Imaging of Tumors in the Cell-Silent
Window. To further study tumor metabolism and angiogenesis,
we conducted metabolic imaging using a recently developed
method of DO-SRS (33). Going beyond structural imaging, DO-
SRS—coupling deuterium oxide probing with SRS microscopy—
could reveal metabolic dynamics of animals in situ (33). The
metabolic incorporation of deuterium from deuterium oxide into
macromolecules produces carbon–deuterium bonds that vibrate
in the cell-silent spectral window. DO-SRS microscopy enables
simultaneous visualization of both lipid and protein synthesis
through spectral unmixing, allowing the study of tumor metab-
olism in an integrated manner (33).
Because infiltrating tumor cells had higher lipid-to-protein ratio
revealed by label-free imaging earlier (Fig. 6C), we hypothesized
that infiltrating tumor cells had reprogrammed metabolism com-
pared with dense tumor cells. To test this hypothesis, we performed
correlative DO-SRS and immunofluorescence on glioblastoma.
Immunolabeling of vimentin not only confirmed the presence of
infiltrating tumor cells but also provided a marker for epithelial-
mesenchymal transition (EMT), which has emerged as a key regu-
lator of tumor invasion (61) and malignancy (62). Based on
vimentin expression and cell morphology, we found dense tumor
cells could be categorized into two groups: one is high vimentin-
expression sphere-shaped cells that are located close to tumor
margins (arrows in Fig. 7A); the other is low vimentin-expression
Fig. 5. Clearing-enhanced volumetric chemical im-
aging of glioblastoma in mouse brain. (A) Repre-
sentative 2D images of the tumor in the whole
coronal slice at increasing imaging depths. (B) Tumor
margins outlined from A. (C and D) Zoomed-in 2D
images of the white-boxed region in A at increasing
imaging depths. (E) Protein/lipid ratiometric image
at 200-μm depth. (F) Plots of protein/lipid signal ra-
tios as a function of imaging depths in tumor and
normal tissues. Error bars indicate SD. (n = 3 for each
data point) Proteins are in magenta and lipids are in
green. Infiltrating glioblastoma cells are indicated by
arrows in C and D. (Scale bars: 1 mm in A, B, and E;
50 μm in C; 20 μm in D.)
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spindle-shaped cells that are narrow and elongated and located far
away from tumor margins (arrowheads in Fig. 7A). Infiltrating
tumor cells were also sphere-shaped with high vimentin expression
similar to sphere-shaped dense tumor cells (Fig. 7 B and C). These
results contradict with canonical phenotypes of mesenchymal cells
—high vimentin expression and spindle-cell morphology, in-
dicating that EMT of these tumor cells is a gradual process with
multiple intermediate or hybrid states instead of an “all-or-none”
process (52, 63). Detailed quantification with DO-SRS (Fig. 7C)
revealed: (i) infiltrating tumor cells exhibited higher activity of
lipid synthesis (indicated by CDL) than both sphere-shaped and
spindle-shaped dense tumor cells; (ii) sphere-shaped dense tumor
cells showed higher activity of lipid synthesis than spindle-shaped
ones; (iii) infiltrating tumor cells and two types of dense tumor
cells had similar levels of newly synthesized proteins (indicated by
CDP); and (iv) infiltrating tumor cells showed higher CDL/CDP
ratio than both sphere-shaped and spindle-shaped dense tumor
cells, which likely contributes to higher lipid-to-protein ratio of
infiltrating tumor cells observed earlier (Fig. 6C). These results
indicate enhanced lipid synthesis is central to the metabolic
reprogramming of infiltrating tumor cells, which agrees with an
emerging role of lipid metabolism in glioblastoma pathology (57–
59). Infiltrating tumor cells were more similar—in cellular
morphology, vimentin expression, and metabolic activities—to
sphere-shaped dense tumor cells than to spindle-shaped dense
tumor cells (Fig. 7C), suggesting an infiltration process that
dense tumor cells acquire the capacity to invade normal tissues
through EMT and enhanced lipid synthesis.
Next we studied the metabolic basis of angiogenesis in tumor.
Based on the high-volume fraction of vasculature in tumor (Fig.
6E), we hypothesized that tumor-associated vasculature had high
activities of protein and lipid synthesis for sustained angiogene-
sis. To test this hypothesis, we conducted volumetric DO-SRS
imaging on glioblastoma with Raman-tailored tissue clearing. As
previously reported (33), tumor tissues exhibited higher activity
of protein synthesis (CDP) than normal tissues (Fig. 8A). What’s
more, tumor vasculature was highlighted in CDP channel, in-
dicating highly active protein synthesis in tumor vasculature (Fig.
8A). We then segmented tumor and normal vasculature (SI
Appendix) and compared their metabolic activities and chemical
composition. As shown in Fig. 8B, tumor vasculature had much
higher signals in CDP and CHP and slightly higher signals in CDL
and CHL than normal blood vessels. These data indicate: (i)
active angiogenesis takes place in the tumor, (ii) metabolic
reprogramming for tumor angiogenesis involves a major increase
in protein synthesis and a minor increase in lipid synthesis, and
(iii) tumor vasculature has a different chemical composition
from normal vasculature. Based on high metabolic activity and
Fig. 6. Segmentation and quantification of brain
glioblastoma tissues using volumetric phasor analy-
sis. (A) Volumetric images of segmented tumor cells,
vasculature, and axons in two different regions of
brain glioblastoma. Arrows indicate infiltrating tu-
mor cells. (Scale bars, 50 μm.) (B) Phasor plots of in-
filtrating tumor cells (n = 6 cells) and dense tumor
cells (n = 6 cells). The plot (Right) is a zoom-in of the
Left. (C) SRS spectra of infiltrating tumor cells (n =
6 cells) and dense tumor cells (n = 6 cells). Error bars
are SD. (D) Histograms of the minimal distances from
individual tumor cells (n = 2,265) to vasculature and
axons. Mean ± SEM are shown near the histograms.
(E) Volume fraction of vasculature in tumor (n = 5)
and normal (n = 3) tissues. Error bars are SEM. (F)
Volume fraction of axons in tumor (n = 3) and nor-
mal (n = 3) tissues. Error bars are SEM. Statistical
significance was determined by pair-sample two-
tailed t test. *P < 0.05 and ***P < 0.001.
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distinct chemical composition of tumor vasculature (Fig. 8B) and
its close association with tumor cells (Fig. 6 D and E), tumor
vasculature could possibly derive from differentiation of glio-
blastoma stem cells into endothelial cells or pericytes, a phe-
nomenon termed vascular mimicry (64–66).
Besides, we observed that in CDL channel, newly synthesized
lipids formed large clusters mainly in the tumor (Fig. 8A). We
then segmented these clusters (SI Appendix) and compared the
volume and metabolic activities of these clusters in tumor and
normal tissues. As shown in Fig. 8C, there are far more clusters
in the tumor than in the normal tissue: the clusters in the tumor
had larger volume than those in the normal tissue, while their
CDL intensities were not significantly different. These results
indicate that tumor tissues exhibited more and larger localized
hotspots of lipid synthesis than normal tissues.
Multimodal Imaging of Tumors. Using brain and subcutaneous
glioblastoma as models, we further extended our method to
multimodal imaging. Correlative two-photon fluorescence and
SRS imaging showed the network of vasculature in the auto-
fluorescence channel and the boundaries between tumor and
normal tissues determined by the SRS channel (SI Appendix,
Fig. S17). Correlative second-harmonic generation and SRS
imaging illustrated collagen fibers from second-harmonic
generation and heterogeneous distributions of proteins and
lipids from SRS (SI Appendix, Fig. S18). These results dem-
onstrate that our technique can be readily combined with
fluorescence imaging and other nonlinear deep-tissue imaging
methods in synergy for the characterization of complex
biological tissues.
Discussion
We have developed a tissue-clearing–enhanced volumetric
chemical imaging technique capable of extending the current
SRS imaging depth greater than 10 times. We designed Raman-
tailored tissue-clearing strategies for the high-wavenumber C-H
region and cell-silent window. Our method achieved clearing-
enhanced SRS microscopy with a greater than 10-fold depth
extension to ∼1 mm in tissues, although several reports dem-
onstrated clearing-enhanced Raman spectroscopy (67, 68). In
addition, we developed a robust volumetric phasor analysis
method to analyze and quantify multispectral images of tissues.
Furthermore, we demonstrated metabolic volumetric chemical
imaging by employing DO-SRS, a newly developed method for
visualizing metabolic dynamics (33).
With the advantages of tissue-clearing–enhanced volumetric
chemical imaging and analyses, we applied this toolbox to 3D
contexts of neurobiology and cancer biology. First, we found in-
creased lipid synthesis at the outer surface of tumor spheroids, in-
dicating rapid cell division and proliferation at the invasion front.
Second, we quantitatively determined the distributions of blood
vessels, axon fibers, and cell bodies in various brain regions. Third,
we delineated tumor margins and unveiled complex 3D structures
of glioblastoma xenografts. Fourth, we found infiltrating glioblas-
toma cells had high lipid-to-protein ratio, high vimentin expression,
and enhanced lipid synthesis compared with dense tumor cells.
Fifth, we found close association between tumor cells and vascu-
lature and tumor vasculature had higher metabolic activities and
higher protein and lipid content than normal vasculature.
Our clearing-enhanced SRS microscopy is complementary to vol-
umetric fluorescence imaging with several distinct advantages. First,
unlike fluorescence, SRS is capable of providing comprehensive
Fig. 7. Correlative DO-SRS and immunofluorescence of glioblastoma. (A) Correlative images of immunolabeled vimentin, label-free SRS, and DO-SRS show two
types of dense tumor cells: arrows indicate sphere-shaped dense tumor cells and arrowheads indicate spindle-shaped dense tumor cells. (Scale bar, 20 μm.) (B)
Correlative images of immunolabeled vimentin, label-free SRS, and DO-SRS show infiltrating tumor cells (arrow). (Scale bar, 20 μm.) (C) Intensities of vimention, CDL,
CDP, and CDL/CDP of infiltrating tumor cells (n = 13 cells), sphere-shaped dense tumor cells (n = 26 cells), and spindle-shaped dense tumor cells (n = 13 cells), from one
mouse. Statistical significance was determined by one-way ANOVA with the Holm–Bonferroni method. **P < 0.01 and ***P < 0.001. NS, not significant.
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chemical information of sample composition, identifying and dis-
tinguishing molecules, such as lipids, proteins, DNA, water, sugars,
cholesterol, and phosphates (29). The spatial distributions, chemical
subtypes (e.g., saturated vs. unsaturated lipids), and detailed con-
formations (e.g., α-helices vs. β-sheets of proteins) of these species
are crucial for their functions. Second, label-free SRS enables
probing chemical structures in tissues without exogenous labels, free
from the difficulties of probe delivery for fluorescence microscopy.
Third, the emerging bioorthogonal chemical imaging platform with
vibrational tags (such as DO-SRS) allows visualization of metabolic
dynamics of biomolecules, such as proteins, lipids, and nucleic acids,
inside tissues and organisms (33, 40, 41). Therefore, volumetric
chemical imaging by clearing-enhanced SRS microscopy can be a
valuable tool for characterizing 3D structures, compositions, dy-
namics, and functions in diverse biological contexts.
Our technique could be further optimized on several fronts. In
terms of next-generation clearing reagents, more chemicals could be
screened to achieve increased depth extension. Instrumentation-
wise, SRS microscopes can be constructed for simultaneous multi-
channel imaging (69–72), hence allowing high-throughput volumetric
chemical imaging. In addition, the clearing-enhanced SRS could be
combined with Bessel-beam SRS tomography for fast 3D imaging
(73). Regarding applications, the Raman-clearing strategies could be
tailored for specialized imaging purposes. For example, by combining
SRS with hydrogel-based clearing [e.g., CLARITY (3)], chemical
imaging of both protein distributions and protein secondary structures
in whole organs may be achievable. Taken together, clearing-
enhanced SRS will find broad use for comprehensive understanding
of structure–function relationships in 3D tissue context.
Methods
Samples were immersed in the clearing solution (8 M urea or 8 M urea supple-
mentedwith 0.2% Triton X-100) formore than 4 d at room temperature andwere
thenmounted in the clearing solution for SRSmicroscopy. The animal experimental
Fig. 8. Metabolic volumetric chemical imaging of
glioblastoma. (A) Three-dimensional reconstruction
of label-free SRS and DO-SRS images. The arrow in-
dicates a blood vessel in the tumor. The arrowhead
indicates a blood vessel in the normal tissue. (Scale
bar, 50 μm.) (B) Intensities of CDP, CDL, CHP, and CHL
of tumor vasculature (n = 7,588) and normal vascu-
lature (n = 1,605) from one mouse. (C) Volume and
CDL intensities of clusters of newly synthesized lipids
in the tumor (n = 6,894) and those in the normal
tissue (n = 136) from one mouse. Statistical signifi-
cance was determined by two-sample two-tailed
t test. ***P < 0.001. NS, not significant.
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protocol (AC-AAAQ0496) was approved by the Institutional Animal Care and Use
Committee at Columbia University. Full details are given in SI Appendix.
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